Skip to main content

MoneyWorks4Me

Claris Lifesciences informs about company updates

01 Jun 2017 Evaluate

Claris Lifesciences (CLL) along with its wholly owned subsidiary Claris Injectables Limited (CIL) has informed that it underwent a successful USFDA Pharmacovigilance (PV) audit from Monday 29th May to Wednesday 31st May with No Observation (i483s).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Redington 359.55
Adani Enterprises 2733.00
Amrapali Industries 33.62
Maxgrow India 182.35
Rashi Peripheral 696.70
View more..